Comparison of TNFα and TNFβ cytolytic mechanisms in human ovarian and cervical carcinoma cell lines

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 258-265

  Powell, C Bethan ^a   Scott, Janet H ^a   Collins, John Leslie ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOXYGENASE; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; DACTINOMYCIN; EMETINE; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CARCINOMA CELL; CYTOLYSIS; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR AFFINITY; UTERINE CERVIX CARCINOMA; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; FEMALE; MOUSE; OVARY TUMOR; PATHOLOGY; UTERINE CERVIX TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; DACTINOMYCIN; EMETINE; FEMALE; HUMANS; LYMPHOTOXIN-ALPHA; MICE; OVARIAN NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 0032194823     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5178     Document Type: Article

References (38)

1. Aggarwal B B, Moffat B, Harkins R N. Human lymphotoxin: production by a lymphoblastoid cell line, purification, and initial characterization. J Biol Chem. 259:1984;686.
2. Aggarwal B B, Henzel W J, Moffat B, Kohr W J, Harkins R N. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J Biol Chem. 260:1985;2334.
3. Gray P W, Aggarwal B B, Benton C V, Bringman T S, Henzel W J, Jarrett J A, Leung D W, Moffat B, Ng P, Svedersky L P, Palladino M A, Nedwin G A. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature. 312:1984;721.
4. Aggarwal B B, Kohr W J, Hass P E, Moffat B, Spencer S A, Henzel W J, Bringman T S, Nedwin G A, Goeddel D V, Harkins R N. Human tumor necrosis factor: production, purification, and characterization. J Biol Chem. 260:1985;2345.
5. Pennica D, Nedwin G E, Hayflick J S, Seeburg P H, Derynck R, Palladino M A, Kohr W J, Aggarwal B B, Goeddel D V. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 312:1984;724.
6. Schuchmann M, Hess S, Bufler P, Brakebusch C, Wallach D, Porter A, Riethmuller G, Engelmann H. Functional discrepancies between tumor necrosis factor and lymphotoxin α explained by trimer stability and distinct receptor interactions. Eur J Immunol. 25:1995;2183.
7. Lewis M, Tartaglia L A, Lee A, Bennett G L, Rice G C, Wong G H, Chen E Y, Goeddel D V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA. 88:1991;2830.
8. Browning J L, Miatkowski K, Sizing I, Griffiths D, Zafari M, Benjamin C D, Meier W, MacKay F. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J Exp Med. 183:1996;867.
9. Iwamoto S, Shibuya I, Takeda K, Takeda M. Lymphotoxin lacks effects on the 75-kDa receptors in cytotoxicity on U-937 cells. Biochem Biophys Res Commun. 199:1994;70.
10. Chaturvedi M M, LaPushin R, Aggarwal B B. Tumor necrosis factor and lymphotoxin: qualitative and quantitative differences in the mediation of early and late cellular responses. J Biol Chem. 269:1994;14575.
11. Carswel E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 72:1975;3666.
12. Ruddle N H, Waskman H B. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. III. Analysis of mechanism. J Exp Med. 128:1968;1267.
13. Qin Z, van Tits L JH, Buurman W A, Blankenstein T. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice. Blood. 85:1995;2779.
14. Selmaj K, Raine C S, Farooq M, Norton W T, Brosnan C F. Cytokine cytotoxicity against oligodendrocytes. J Immunol. 147:1991;1522.
15. Kramer S M, Carver M E, Apperson S M. Comparison of TNFα and TNFβ cytolytic biological activity in serum free bioassay. Lymphokine Res. 5:1986;139.
16. McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel J P. Effect of tumor necrosis factor α and β on human oligodendrocytes and neurons in culture. Int J Dev Neurosci. 13:1995;369.
17. Ruddle N H, Millet I, Picarella D D, Kratz A, Li C B, Flavell R A. Tumor Necrosis Factor and Cellular Biology and Clinical Relevance. 1993;Karger, Basel.
18. Browning J, Ribolini A. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J Immunol. 143:1989;1859.
19. Rothstein J L, Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA. 85:1988;607.
20. Powell C B, Mutch D G, Massad L S, Kao M-S, Collins J L. Common expression of a protein synthesis dependent resistance mechanism that prevents lysis by tumor necrosis factor alpha among carcinoma cell lines derived from gynecologic malignancies. Cancer Immunol Immunother. 32:1990;131.
21. Mutch D G, Massad L S, Powell C B, Kao M-S, Collins J L. Proliferative and antiproliferative effects of interferon gamma and tumor necrosis factor alpha on cell lines derived from cervical and ovarian malignancies. Am J Obstet Gynecol. 163:1990;1920.
22. Massad L S, Mutch D G, Powell C B, Kao M-S, Collins J L. Inhibition of protein synthesis increases the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecologic malignancies. Cancer Immunol Immunother. 33:1991;183.
23. 2. Cancer Res. 52:1992;866.
24. Herzog T J, Collins J L. Comparison of the cytostatic and cytolytic activity of tumor necrosis factor alpha and interleukin-1 alpha in human malignant cell lines. Cytokine. 4:1992;214.
25. Powell C B, Herzog T J, Scott J H, Collins J L. Evidence for a protein synthesis dependent and independent TNFα cytolytic mechanism. Gynecol Oncol. 58:1995;327.
26. Powell C B, Scott J H, Collins J L. Characterization of the protein synthesis independent TNFα lytic mechanism in human ovarian and cervical carcinoma cell lines. Gynecol Oncol. 62:1996;42.
27. Sarih M, Souvannavong V, Brown S C, Adam A. Silica induces apoptosis in macrophages and the release of interleukin-1α and interleukin-1β J Leukocyte Biol. 54:1993;407.
28. Snedecor G W, Cochran W G. Statistical Methods. 1967;Iowa State Univ. Press, Ames.
29. Yasumoto K, Yamamoto A, Mitsuda H. Effects of phenolic antioxidants on lipoxygenase reaction. Agr Biol Chem. 34:1970;1162.
30. Capdevila J, Gil L, Orellana M, Marnett L J, Mason J I, Yadagiri P, Falck J R. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 261:1988;257.
31. Beetens J R, Loots W, Somers Y, Coene M C, De Clerck F. Ketoconazole inhibits the biosynthesis of leukotrienesin vitroin vivo. Biochem Pharmacol. 35:1986;883.
32. Sellmayer A, Uedelhoven W M, Weber P C, Bonventre J V. Endogenous noncyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J Biol Chem. 266:1991;3800.
33. Kramer S M, Carver M E, Apperson S M. Comparison of TNF-alpha and TNF-beta cytolytic biological activities in a serum-free bioassay. Lymphokine Res. 5:1986;139.
34. Brinkmann U, Brinkmann E, Gallo M, Scherf U, Pastan I. Role of CAS, a human homologue to the yeast chromosome segregation gene CSE1, in toxin and tumor necrosis factor mediated apoptosis. Biochem. 35:1996;6891.
35. Tartaglia I A, Goedell D V. Two TNF receptors. Immunol Today. 13:1992;151.
36. VanOstade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W. Human TNF mutants with selective activity on the p55 receptor. Nature. 361:1993;266.
37. Higuchi M, Aggarwal B B. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol. 152:1994;3550.
38. Lantz M, Gullberg U, Nilsson E, Olsson I. Characterizationin vitro. J Clin Invest. 86:1990;1396.